RUNX1 Mutations in Inherited and Sporadic Leukemia.

Item

http://www.wikidata.org/entity/Q50074717

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

RUNX1 Mutations in Inherited and Sporadic Leukemia.

@en

RUNX1 Mutations in Inherited and Sporadic Leukemia.

@nl

type

Item

label

RUNX1 Mutations in Inherited and Sporadic Leukemia.

@en

RUNX1 Mutations in Inherited and Sporadic Leukemia.

@nl

prefLabel

RUNX1 Mutations in Inherited and Sporadic Leukemia.

@en

RUNX1 Mutations in Inherited and Sporadic Leukemia.

@nl

P1476

RUNX1 Mutations in Inherited and Sporadic Leukemia.

@en

P2093

Nancy A Speck

http://www.w3.org/2001/XMLSchema#string

P2860

Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1

Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia

The t(8;21) translocation in acute myeloid leukemia results in production of an AML1-MTG8 fusion transcript

RUNX1 mutations in acute myeloid leukemia: results from a comprehensive genetic and clinical analysis from the AML study group.

RUNX1 mutations are associated with poor outcome in younger and older patients with cytogenetically normal acute myeloid leukemia and with distinct gene and MicroRNA expression signatures.

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico-pathologic and genetic features.

Genomic Classification and Prognosis in Acute Myeloid Leukemia.

Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)

The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties

P304

111

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FCELL.2017.00111

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Dana Bellissimo

P577

2017-12-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29326930

http://www.w3.org/2001/XMLSchema#string

P921

leukemia

P932

5742424

http://www.w3.org/2001/XMLSchema#string